|
Enhancing Immunotherapy for Triple-Negative and HER2+ Breast Cancer Using EpCAM Aptamer-siRNAMediated Gene Knockdown
Enhancing Immunotherapy for Triple-Negative and HER2+ Breast Cancer Using EpCAM Aptamer-siRNAMediated Gene Knockdown
Background
Triple-negative (TNBC) and HER2+ breast cancers (BCs) are especially aggressive tumors with the worst prognosis as they are prone to relapse and metastasize post chemo- or targeted therapy. Immunotherapy provides...
Published: 3/9/2026
|
Updated: 7/28/2023
|
Inventor(s): Judy Lieberman, Ying Zhang
Keywords(s): Cancer, Oncology
Category(s): Technology Classifications > Invention Type, Technology Classifications > Invention Type > Therapeutics, Technology Classifications > Disease Area, Technology Classifications > Disease Area > Oncology
|
